Original Research
Published on 30 Jul 2025
Predicting recurrence and recurrence-free survival in initially unresectable hepatocellular carcinoma: a novel nomogram for patients undergoing conversion hepatectomy with lenvatinib, PD-1 inhibitor, and interventional therapy
in Cancer Immunity and Immunotherapy
- 226 views